Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the effect of RO4607381 (900 mg daily) on HDL C in patients with CHD or a CHD risk equivalent. • To evaluate the 24-week safety profile of RO4607381. In addition to assessing the general safety profile of RO4607381, MRI imaging will be performed to evaluate potential changes in mesenteric lymph nodes.
Critère d'inclusion
- CHD or CHD Risk Equivalent